Literature DB >> 23032088

Atypical mycobacterial exit-site infection and peritonitis in peritoneal dialysis patients on prophylactic exit-site gentamicin cream.

Man-wai Lo1, Siu-ka Mak, Yuk-yi Wong, Kwok-chi Lo, Shuk-fan Chan, Gensy M W Tong, Kin-yee Lo, Ping-nam Wong, Cindy W S Tse, Kai-Man Kam, Andrew K M Wong.   

Abstract

We report 9 cases of exit-site infection and continuous ambulatory peritoneal dialysis peritonitis associated with atypical mycobacteria. All patients had been using topical gentamicin cream as prophylaxis for exit-site infection before the onset of these infections. Gentamicin cream is postulated to be a potential risk factor for atypical mycobacterial infection because of selective pressure on other micro-organisms. The microbiology of atypical mycobacteria and the treatment for atypical mycobacterial infections are discussed.

Entities:  

Keywords:  Atypical mycobacterial infection; exit site; peritonitis

Mesh:

Substances:

Year:  2012        PMID: 23032088      PMCID: PMC3649895          DOI: 10.3747/pdi.2011.00184

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  18 in total

Review 1.  Exit-site and catheter care: review of important issues.

Authors:  R D Swartz
Journal:  Adv Perit Dial       Date:  1999

Review 2.  Prevention and management of peritonitis and exit-site infection in patients on continuous ambulatory peritoneal dialysis.

Authors:  V Vargemezis; E Thodis
Journal:  Nephrol Dial Transplant       Date:  2001       Impact factor: 5.992

3.  Anonymous mycobacteria in pulmonary disease.

Authors:  E H RUNYON
Journal:  Med Clin North Am       Date:  1959-01       Impact factor: 5.456

4.  Classification of normal and diseased exit sites.

Authors:  Z J Twardowski; B F Prowant
Journal:  Perit Dial Int       Date:  1996       Impact factor: 1.756

5.  Water as a source of potentially pathogenic mycobacteria.

Authors:  S Goslee; E Wolinsky
Journal:  Am Rev Respir Dis       Date:  1976-03

6.  Simple and rational approach to the identification of Mycobacterium tuberculosis, Mycobacterium avium complex species, and other commonly isolated mycobacteria.

Authors:  D A Wong; P C Yip; D T Cheung; K M Kam
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

Review 7.  Therapy of nontuberculous mycobacterial infections.

Authors:  Reena Jogi; Stephen K Tyring
Journal:  Dermatol Ther       Date:  2004       Impact factor: 2.851

Review 8.  Exit-site infection in continuous ambulatory peritoneal dialysis: a review.

Authors:  M A Luzar
Journal:  Perit Dial Int       Date:  1991       Impact factor: 1.756

9.  Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use.

Authors:  R Sutherland; R J Boon; K E Griffin; P J Masters; B Slocombe; A R White
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

Review 10.  Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis.

Authors:  Gaosi Xu; Weiping Tu; Chengyun Xu
Journal:  Nephrol Dial Transplant       Date:  2009-08-13       Impact factor: 5.992

View more
  14 in total

1.  Laparoscopic-assisted catheter insertion for continuous ambulatory peritoneal dialysis: A case report of simple technique for optimal placement.

Authors:  Tomohide Hori; Masaya Nakauchi; Kazuhiro Nagao; Fumitaka Oike; Takahiro Tanaka; Daigo Gunji; Noriyuki Okada
Journal:  World J Gastrointest Surg       Date:  2013-10-27

2.  Peritoneal Dialysis-Associated Peritonitis Caused by Mycobacterium abscessus.

Authors:  Tsung-Kun Yang; Jia-Jung Lee; Po-Liang Lu; Hung-Tien Kuo; Mei-Chuan Kuo; Hung-Chun Chen
Journal:  Perit Dial Int       Date:  2015 May-Jun       Impact factor: 1.756

Review 3.  Peritoneal dialysis-related infections recommendations: 2016 update. What is new?

Authors:  Vassilios Liakopoulos; Olga Nikitidou; Theofanis Kalathas; Stefanos Roumeliotis; Marios Salmas; Theodoros Eleftheriadis
Journal:  Int Urol Nephrol       Date:  2017-06-01       Impact factor: 2.370

4.  Mycobacterium abscessus exit-site infection in peritoneal dialysis patients: should we ever aim to salvage the catheter?

Authors:  Gajapathiraju Chamarthi; Mayanka Kamboj; Lennox K Archibald; Ashutosh M Shukla
Journal:  CEN Case Rep       Date:  2020-07-13

5.  Secondary atypical mycobacterial infection after peritoneal catheter removal.

Authors:  Maggie My Mok; Maggie Km Ma; Desmond Yh Yap; Tak M Chan; Fei Mf Lam
Journal:  Int Wound J       Date:  2014-05-14       Impact factor: 3.315

6.  Peritoneal dialysis-associated catheter infection caused by Mycobacterium abscessus in an elderly patient who was successfully treated with catheter removal.

Authors:  Arata Hibi; Takahisa Kasugai; Keisuke Kamiya; Keisuke Kamiya; Chiharu Ito; Satoru Kominato; Ken Mizuguchi; Toshiyuki Miura; Katsushi Koyama
Journal:  CEN Case Rep       Date:  2017-08-09

7.  Alternating Mupirocin/Gentamicin is Associated with Increased Risk of Fungal Peritonitis as Compared with Gentamicin Alone - Results of a Randomized Open-Label Controlled Trial.

Authors:  Ping-Nam Wong; Gensy M W Tong; Yuk-Yi Wong; Kin-Yee Lo; Shuk-Fan Chan; Man-Wai Lo; Kwok-Chi Lo; Lo-Yi Ho; Cindy W S Tse; Siu-Ka Mak; Andrew K M Wong
Journal:  Perit Dial Int       Date:  2016-04-04       Impact factor: 1.756

8.  Clinical manifestation of macrolide antibiotic toxicity in CKD and dialysis patients.

Authors:  Terry King-Wing Ma; Kai-Ming Chow; Agnes Shin Man Choy; Bonnie Ching-Ha Kwan; Cheuk-Chun Szeto; Philip Kam-Tao Li
Journal:  Clin Kidney J       Date:  2014-09-18

9.  Simultaneous catheter removal and reinsertion, is it acceptable in M. abscessus exit site infection?

Authors:  Gajapathiraju Chamarthi; Dhruv Modi; Kenneth Andreoni; Ashutosh M Shukla
Journal:  CEN Case Rep       Date:  2021-03-16

Review 10.  ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.

Authors:  Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Javier de Arteaga; Stanley Fan; Ana E Figueiredo; Douglas N Fish; Eric Goffin; Yong-Lim Kim; William Salzer; Dirk G Struijk; Isaac Teitelbaum; David W Johnson
Journal:  Perit Dial Int       Date:  2016-06-09       Impact factor: 1.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.